ARDS Stock News

Popular stocks:

Suncor Energy

TOP Stocks:

Shares of other companies:

Aridis Pharmaceuticals (ARDS) Stock Forecast for 2023 – 2026. Sell or Buy?

Updated: December 8, 2023 (17:07)

Sector: Healthcare

The share price of Aridis Pharmaceuticals, Inc. (ARDS) now

Latest session on the 7th of December for

Aridis Pharmaceuticals, Inc. is positive

Trading Volume: 125042

Open: 0.074 / High: 0.084 / Low: 0.074

What analysts predict: $

52-week High/Low: $ / $

50/200 Day Moving Average: $ / $

This figure corresponds to the Average Price over the previous 50/200 days. For Aridis Pharmaceuticals stocks, the 50-day moving average is the support level today.

For Aridis Pharmaceuticals stocks, the 200-day moving average is the support level today.

Are you interested in Aridis Pharmaceuticals, Inc. stocks and want to buy them, or are they already in your portfolio? If yes, then on this page you will find useful information about the dynamics of the Aridis Pharmaceuticals stock price in 2024, 2025, 2026, 2027, 2028. How much will one Aridis Pharmaceuticals share be worth in 2024 - 2028?

When should I take profit in Aridis Pharmaceuticals stock? When should I record a loss on Aridis Pharmaceuticals stock? What are analysts' forecasts for Aridis Pharmaceuticals stock? What is the future of Aridis Pharmaceuticals stock? We forecast Aridis Pharmaceuticals stock performance using neural networks based on historical data on Aridis Pharmaceuticals stocks. Also, when forecasting, technical analysis tools are used, world geopolitical and news factors are taken into account.

Aridis Pharmaceuticals stock prediction results are shown below and presented in the form of graphs, tables and text information, divided into time intervals. (Next month, 2024, 2025, 2026, 2027 and 2028) The final quotes of the instrument at the close of the previous trading day are a signal to adjust the forecasts for Aridis Pharmaceuticals shares. This happens once a day.

Historical and forecast chart of Aridis Pharmaceuticals stock

The chart below shows the historical price of Aridis Pharmaceuticals stock and a prediction chart for the next month. For convenience, prices are divided by color. Forecast prices include: Optimistic Forecast, Pessimistic Forecast, and Weighted Average Best Forecast. Detailed values for the Aridis Pharmaceuticals stock price can be found in the table below.

Long-term forecasts by years.

Aridis Pharmaceuticals, Inc. Is a biopharmaceutical company specializing in the discovery and development of targeted immunotherapy using fully human monoclonal antibodies (mAbs) to treat infections. MABs represent a treatment approach that allows the human immune system to fight infections and is designed to overcome the disadvantages associated with current therapies, such as increased drug resistance, short response times, negative effects on the human microbiome, and lack of differentiation between treatment alternatives. Its product pipeline includes human MABs that target specific pathogens associated with bacterial infections, most notably hospital-acquired pneumonia (HAP) and ventilator-associated pneumonia (VAP). Its leading candidate product, AR-301, targets the alpha toxin produced by the gram-positive bacteria Staphylococcus aureus, a common pathogen associated with HAP and VAP. Its AR-101 (Aerumab) is a fully human immunoglobulin M targeting P. aeruginosa serotype O11.

Aridis Pharmaceuticals daily forecast for a month

Date	Target	Pes.	Opt.	Vol., %
Dec 10	0.08	0.08	0.08	3.69
Dec 11	0.08	0.08	0.08	3.84
Dec 12	0.08	0.08	0.08	3.83
Dec 13	0.08	0.08	0.08	4.12
Dec 14	0.08	0.08	0.08	3.14
Dec 15	0.08	0.08	0.08	5.43
Dec 16	0.08	0.08	0.08	2.80
Dec 17	0.08	0.08	0.08	3.87
Dec 18	0.08	0.08	0.08	6.20
Dec 19	0.08	0.08	0.08	5.17
Dec 20	0.08	0.08	0.08	3.19
Dec 21	0.08	0.08	0.08	6.18
Dec 22	0.08	0.08	0.08	5.01
Dec 23	0.08	0.08	0.08	3.75
Dec 24	0.08	0.08	0.09	5.75
Dec 25	0.08	0.08	0.09	2.73
Dec 26	0.09	0.09	0.09	4.68
Dec 27	0.09	0.08	0.09	5.28
Dec 28	0.09	0.08	0.09	3.82
Dec 29	0.09	0.09	0.09	2.51
Dec 30	0.09	0.08	0.09	3.69
Dec 31	0.09	0.09	0.09	2.55
Jan 01	0.09	0.09	0.09	3.60
Jan 02	0.09	0.09	0.09	4.82
Jan 03	0.09	0.09	0.09	3.93
Jan 04	0.09	0.09	0.09	5.03
Jan 05	0.09	0.09	0.09	4.07
Jan 06	0.09	0.09	0.09	4.93
Jan 07	0.09	0.09	0.09	4.04
Jan 08	0.09	0.09	0.09	3.35

Aridis Pharmaceuticals Daily Price Targets

Aridis Pharmaceuticals Stock Forecast 12-10-2023.

Forecast target price for 12-10-2023: $0.08.
Positive dynamics for Aridis Pharmaceuticals shares will prevail with possible volatility of 3.562%.
Pessimistic target level: 0.08
Optimistic target level: 0.08

Aridis Pharmaceuticals Stock Forecast 12-11-2023.

Forecast target price for 12-11-2023: $0.08.
Positive dynamics for Aridis Pharmaceuticals shares will prevail with possible volatility of 3.701%.
Pessimistic target level: 0.08
Optimistic target level: 0.08

Aridis Pharmaceuticals Stock Forecast 12-12-2023.

Forecast target price for 12-12-2023: $0.08.
Positive dynamics for Aridis Pharmaceuticals shares will prevail with possible volatility of 3.688%.
Pessimistic target level: 0.08
Optimistic target level: 0.08

Aridis Pharmaceuticals Stock Forecast 12-13-2023.

Forecast target price for 12-13-2023: $0.08.
Negative dynamics for Aridis Pharmaceuticals shares will prevail with possible volatility of 3.957%.
Pessimistic target level: 0.08
Optimistic target level: 0.08

Aridis Pharmaceuticals Stock Forecast 12-14-2023.

Forecast target price for 12-14-2023: $0.08.
Positive dynamics for Aridis Pharmaceuticals shares will prevail with possible volatility of 3.046%.
Pessimistic target level: 0.08
Optimistic target level: 0.08

Aridis Pharmaceuticals Stock Forecast 12-15-2023.

Forecast target price for 12-15-2023: $0.08.
Positive dynamics for Aridis Pharmaceuticals shares will prevail with possible volatility of 5.154%.
Pessimistic target level: 0.08
Optimistic target level: 0.08

ARDS (ARDS) Monthly Stock Prediction for 2024

Month	Target	Pes.	Opt.	Vol., %
Jan.	0.08	0.07	0.09	16.98
Feb.	0.09	0.08	0.10	17.26
Mar.	0.09	0.09	0.10	12.68
Apr.	0.08	0.07	0.09	14.12
May.	0.06	0.06	0.07	13.91
Jun.	0.07	0.06	0.07	12.10
Jul.	0.07	0.07	0.07	9.55
Aug.	0.07	0.06	0.07	13.97
Sep.	0.07	0.06	0.07	18.91
Oct.	0.06	0.06	0.07	13.41
Nov.	0.06	0.05	0.07	17.19
Dec.	0.06	0.05	0.06	17.06

Full forecast for 2024

Aridis Pharmaceuticals forecast for this year

Aridis Pharmaceuticals Stock Prediction for Jan 2024

An uptrend is forecast for this month with an optimal target price of $0.08064. Pessimistic: $0.07. Optimistic: $0.09

Aridis Pharmaceuticals Stock Prediction for Feb 2024

An uptrend is forecast for this month with an optimal target price of $0.0892846. Pessimistic: $0.08. Optimistic: $0.10

Aridis Pharmaceuticals Stock Prediction for Mar 2024

An uptrend is forecast for this month with an optimal target price of $0.0912846. Pessimistic: $0.09. Optimistic: $0.10

Aridis Pharmaceuticals Stock Prediction for Apr 2024

An downtrend is forecast for this month with an optimal target price of $0.0771172. Pessimistic: $0.07. Optimistic: $0.09

Aridis Pharmaceuticals Stock Prediction for May 2024

An downtrend is forecast for this month with an optimal target price of $0.0647785. Pessimistic: $0.06. Optimistic: $0.07

Aridis Pharmaceuticals Stock Prediction for Jun 2024

An uptrend is forecast for this month with an optimal target price of $0.0662295. Pessimistic: $0.06. Optimistic: $0.07

Aridis Pharmaceuticals Stock Prediction for Jul 2024

An uptrend is forecast for this month with an optimal target price of $0.0714219. Pessimistic: $0.07. Optimistic: $0.07

Aridis Pharmaceuticals Stock Prediction for Aug 2024

An downtrend is forecast for this month with an optimal target price of $0.066051. Pessimistic: $0.06. Optimistic: $0.07

Aridis Pharmaceuticals Stock Prediction for Sep 2024

An downtrend is forecast for this month with an optimal target price of $0.0657339. Pessimistic: $0.06. Optimistic: $0.07

Aridis Pharmaceuticals Stock Prediction for Oct 2024

An downtrend is forecast for this month with an optimal target price of $0.0649977. Pessimistic: $0.06. Optimistic: $0.07

Aridis Pharmaceuticals Stock Prediction for Nov 2024

An downtrend is forecast for this month with an optimal target price of $0.0614618. Pessimistic: $0.05. Optimistic: $0.07

Aridis Pharmaceuticals Stock Prediction for Dec 2024

An downtrend is forecast for this month with an optimal target price of $0.0569382. Pessimistic: $0.05. Optimistic: $0.06

Aridis Pharmaceuticals (ARDS) Monthly Stock Prediction for 2025

Month	Target	Pes.	Opt.	Vol., %
Jan	0.05	0.05	0.06	20.06
Feb	0.06	0.06	0.06	9.98
Mar	0.06	0.05	0.06	21.99
Apr	0.06	0.06	0.07	12.89
May	0.07	0.06	0.07	19.14
Jun	0.07	0.06	0.08	19.26
Jul	0.08	0.07	0.08	7.80
Aug	0.07	0.06	0.07	11.32
Sep	0.07	0.06	0.08	18.37
Oct	0.07	0.06	0.07	14.40
Nov	0.08	0.07	0.08	9.02
Dec	0.09	0.08	0.09	10.35

Full forecast for 2025

Aridis Pharmaceuticals (ARDS) Monthly Stock Prediction for 2026

Month	Target	Pes.	Opt.	Vol., %
Jan	0.09	0.08	0.10	20.71
Feb	0.10	0.09	0.11	17.03
Mar	0.10	0.10	0.11	12.68
Apr	0.10	0.09	0.10	15.95
May	0.09	0.08	0.09	11.61
Jun	0.09	0.08	0.10	17.57
Jul	0.09	0.08	0.10	14.91
Aug	0.08	0.07	0.09	15.35
Sep	0.09	0.08	0.10	19.24
Oct	0.10	0.09	0.11	19.91
Nov	0.11	0.10	0.13	18.44
Dec	0.12	0.10	0.13	18.45

Full forecast for 2026

Aridis Pharmaceuticals (ARDS) Monthly Stock Prediction for 2027

Month	Target	Pes.	Opt.	Vol., %
Jan	0.12	0.11	0.13	16.02
Feb	0.12	0.11	0.13	16.09
Mar	0.12	0.11	0.13	13.15
Apr	0.12	0.10	0.13	19.12
May	0.11	0.10	0.12	17.50
Jun	0.10	0.10	0.11	7.85
Jul	0.10	0.09	0.11	15.18
Aug	0.09	0.09	0.10	10.38
Sep	0.11	0.10	0.12	18.48
Oct	0.10	0.10	0.12	18.14
Nov	0.12	0.11	0.13	14.14
Dec	0.12	0.11	0.12	8.38

Full forecast for 2027

Aridis Pharmaceuticals (ARDS) Monthly Stock Prediction for 2028

Month	Target	Pes.	Opt.	Vol., %
Jan	0.11	0.10	0.12	20.77
Feb	0.13	0.12	0.14	12.74
Mar	0.14	0.13	0.16	18.05
Apr	0.12	0.11	0.14	16.69
May	0.12	0.12	0.13	11.57
Jun	0.12	0.10	0.12	16.97
Jul	0.12	0.11	0.14	18.63
Aug	0.12	0.11	0.13	16.74
Sep	0.12	0.11	0.13	13.87
Oct	0.11	0.10	0.12	20.48
Nov	0.11	0.10	0.11	14.01
Dec	0.12	0.11	0.12	11.96

Full forecast for 2028

Aridis Pharmaceuticals information and performance

Aridis Pharmaceuticals Address

N/A

Market Capitalization: N/A $

Market capitalization of the Aridis Pharmaceuticals, Inc. is the total market value of all issued shares of a company. It is calculated by the formula multiplying the number of ARDS shares in the company outstanding by the market price of one share.

EBITDA: N/A $

EBITDA of Aridis Pharmaceuticals is earnings before interest, income tax and depreciation of assets.

PE Ratio: N/A

P/E ratio (price to earnings) - shows the ratio between the price of a share and the company's profit

PEG Ratio: N/A

Price/earnings to growth

DPS: N/A

Dividend Per Share is a financial indicator equal to the ratio of the company's net profit available for distribution to the annual average of ordinary shares.

DY: N/A

Dividend yield is a ratio that shows how much a company pays in dividends each year at the stock price.

EPS: N/A

EPS shows how much of the net profit is accounted for by the common share.

Quarterly Earnings Growth YOY: N/A

Quarterly Revenue Growth YOY: N/A

Trailing PE: N/A

Trailing P/E depends on what has already been done. It uses the current share price and divides it by the total earnings per share for the last 12 months.

Forward PE: N/A

Forward P/E uses projections of future earnings instead of final numbers.

EV To Revenue: N/A

Enterprise Value (EV) /Revenue

EV To EBITDA: N/A

The EV / EBITDA ratio shows the ratio of the cost (EV) to its profit before tax, interest and amortization (EBITDA).

Shares Outstanding: N/A

Number of issued ordinary shares

Shares Float: N/A

Number of freely tradable shares

Shares Short Prior Month: N/A

Shares Short Prior Month - the number of shares in short positions in the last month.

Short Ratio: N/A

Percent Insiders: N/A

Percent Institutions: N/A

Related stocks from Healthcare sector

Boston Scientific Corp. (BSX)

Sorrento Therapeutics, Inc. (SRNE)

Sundial Growers Inc. (SNDL)

Seagen Inc. (SGEN)

Vallon Pharmaceuticals, Inc. (VLON)

Align Technology, Inc. (ALGN)

Immix Biopharma, Inc. (IMMX)

Nutex Health Inc. (NUTX)

Becton Dickinson and Company (BDX)

LifeStance Health Group, Inc. (LFST)

Disclaimer:

All forecast data on the site are provided for informational purposes of using neural forecasting tools in the financial market and are not a call to action and, moreover, are not trading signals. When using the forecast data, the investor assumes all financial risks. The pandaforecast.com portal is not responsible for the loss of your money in the stock market as a result of using the information contained on the site.

<img data-src="/images/stock/ARDS.svg" class="img_30 lazyload" src="data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw=="><noscript><img class="img_30" src="/images/stock/ARDS.svg"> Aridis Pharmaceuticals (ARDS) Stock Forecast for 2023 – 2026. Sell or Buy?